Free Trial

Encompass Health Co. (NYSE:EHC) Stock Holdings Raised by Integral Health Asset Management LLC

Encompass Health logo with Medical background

Integral Health Asset Management LLC raised its position in Encompass Health Co. (NYSE:EHC - Free Report) by 9.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 300,000 shares of the company's stock after purchasing an additional 25,000 shares during the period. Encompass Health accounts for approximately 2.4% of Integral Health Asset Management LLC's portfolio, making the stock its 9th biggest holding. Integral Health Asset Management LLC owned approximately 0.30% of Encompass Health worth $27,705,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. raised its holdings in shares of Encompass Health by 0.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 644,764 shares of the company's stock worth $59,544,000 after acquiring an additional 4,345 shares during the period. Merit Financial Group LLC purchased a new position in shares of Encompass Health during the 4th quarter worth $374,000. BI Asset Management Fondsmaeglerselskab A S purchased a new position in shares of Encompass Health during the 4th quarter worth $4,160,000. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares during the period. Finally, US Bancorp DE raised its holdings in shares of Encompass Health by 9.6% during the 4th quarter. US Bancorp DE now owns 1,380 shares of the company's stock worth $127,000 after acquiring an additional 121 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.

Analysts Set New Price Targets

EHC has been the topic of several research analyst reports. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Royal Bank of Canada boosted their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a report on Monday, April 28th. StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Sunday, May 11th. Barclays boosted their price objective on shares of Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday, April 25th. Finally, UBS Group boosted their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a report on Monday, April 28th. Nine research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Buy" and an average price target of $120.86.

Get Our Latest Report on Encompass Health

Encompass Health Price Performance

EHC stock traded up $1.17 on Friday, reaching $120.94. 904,433 shares of the company's stock were exchanged, compared to its average volume of 694,702. The stock has a fifty day moving average of $105.43 and a 200-day moving average of $100.74. Encompass Health Co. has a twelve month low of $82.74 and a twelve month high of $121.28. The firm has a market cap of $12.19 billion, a PE ratio of 27.12, a P/E/G ratio of 2.31 and a beta of 0.91. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. The company had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Encompass Health's revenue was up 10.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.12 earnings per share. As a group, equities analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's payout ratio is currently 14.05%.

Insider Activity at Encompass Health

In related news, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the transaction, the insider now directly owns 11,958 shares in the company, valued at approximately $1,394,422.38. This represents a 26.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president now owns 79,710 shares in the company, valued at $9,149,910.90. This trade represents a 11.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.00% of the company's stock.

Encompass Health Profile

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Featured Stories

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Should You Invest $1,000 in Encompass Health Right Now?

Before you consider Encompass Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Encompass Health wasn't on the list.

While Encompass Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines